Incidence, Risk Factors, and Clinical Outcomes of Active Tuberculosis in Kidney Transplant Recipients From Romania: A Single‐Center Study
Transplant Infectious Disease · 2025
DOI: 10.1111/tid.70156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Bogdan Marian Sorohan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Carol Davila University of Medicine and Pharmacy, Bucharest, Romania. Hauptthemen laut MEDLINE: Kidney Transplantation, Tuberculosis. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
The present study aimed to assess the incidence of active TB, risk factors associated with TB and KT outcomes among a group of KTR from Romania.
Methods
This single‐center, nested case‐control study, included 22 KTR with active TB and 88 KTR without active TB (matched 1:4) identified from 1485 patients who underwent KT at Fundeni Clinical Institute between 2002 and 2017.
Results
The incidence of active TB among the cohort was 1.48% with a median time to occurrence of 60.26 months (IQR: 30.75–102.50) after KT. Multivariate conditional logistic regression showed that history of active TB before KT (OR = 17.97 [95% CI: 1.35–238.22], p = 0.02) and anti‐thymocyte globulin induction (OR = 2.14 [95% CI: 1.10–4.24], p = 0.02) were independent risk factors associated with TB development. Patient survival ( p = 0.03), overall ( p < 0.001) and death‐censored graft survival ( p < 0.001) were significantly lower in KTR with active TB than in controls during the follow‐up period. Kidney function was not significantly different between TB cases and controls at the last follow‐up ( p = 0.57) in an adjusted analysis.
Conclusion
This study was the first to evaluate active TB in KTR from Romania and found a higher incidence of active TB than that in the general population and a late onset of infection. TB had a negative impact on both patient and graft survival. Screening for latent TB, judicious prophylaxis, rigorous monitoring after KT and tailoring of the immunosuppression could be effective strategies to reduce the burden of TB among KTR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
- Department of Kidney Transplantation, Fundeni Clinical Institute, Bucharest, Romania.
- Department of Nephrology, Fundeni Clinical Institute, Bucharest, Romania.
- Department of Nephrology, Constanța County Emergency Clinical Hospital, Constanța, Romania.
- Department of Pneumology, Marius Nasta Institute of Pneumology, Bucharest, Romania.
- Department of Radiology, Medical Imaging and Interventional Radiology, Dr. Carol Davila Central Military Emergency University Hospital, Bucharest, Romania.
Zitieren
APA
Sorohan, B. M., Tacu, D., Bucșa, C., Asavei, A., Crăciun, T., Borboșanu, N., Dimofte, G., Constantin, G., Ciolan, G., Obrișcă, B., Ismail, G., & Baston, O. M. (2025). Incidence, Risk Factors, and Clinical Outcomes of Active Tuberculosis in Kidney Transplant Recipients From Romania: A Single‐Center Study. Transplant Infectious Disease. https://doi.org/10.1111/tid.70156
Vancouver
Sorohan BM, Tacu D, Bucșa C, Asavei A, Crăciun T, Borboșanu N, et al. Incidence, Risk Factors, and Clinical Outcomes of Active Tuberculosis in Kidney Transplant Recipients From Romania: A Single‐Center Study. Transplant Infectious Disease. 2025. doi:10.1111/tid.70156
BibTeX
@article{Sorohan2025,
author = {Sorohan, Bogdan Marian and Tacu, Dorina and Bucșa, Cristina and Asavei, Andreea and Crăciun, Teodora and Borboșanu, Nicoleta and Dimofte, George and Constantin, Gîngu and Ciolan, Gina and Obrișcă, Bogdan and Ismail, Gener and Baston, Oana-Mădălina},
title = {Incidence, Risk Factors, and Clinical Outcomes of Active Tuberculosis in Kidney Transplant Recipients From Romania: A Single‐Center Study},
journal = {Transplant Infectious Disease},
year = {2025},
doi = {10.1111/tid.70156}
}
EUVIMED